NYSE: PTHS
Pelthos Therapeutics insiders
The officers, directors and 10% owners of Pelthos Therapeutics Inc. who hold the most stock, valued at the live PTHS price.
$6.99
PTHS today −$110K (−1.55%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their PTHS stock
- $11.3M
- Market value
- $27.5M
- Held by ranked insiders
- 41.0%
Insiders by value of PTHS holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Todd C. Davis | Director | 1,575,834 | $11.0M | 40.1% | 1694th |
| 2 | Peter Greenleaf | Director | 23,087 | $161K | 0.59% | 4044th |
| 3 | Matthew Pauls | Director | 13,578 | $95K | 0.35% | 12362nd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Pelthos Therapeutics; see each profile for the filing.